Ludwig Enterprises, Inc. (LUDG): Total Liabilities
$4.64M
As of 2025-12-31
$5.29M
As of 2026-03-31
+51.2%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.64M | +80.0% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $2.58M | +63.6% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $1.57M | +17.3% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $1.34M | n/a | 2024-04-16, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Ludwig Enterprises, Inc. (LUDG) | 2025-12-31 | $4.64M | +80.0% |
| First Choice Healthcare Solutions, Inc. (FCHS) | 2025-12-31 | $43.58M | +17.8% |
| Advanced Biomed Inc. (ADVB) | 2025-06-30 | $3.03M | +8.5% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $637.9K | -69.8% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $837.3K | -27.4% |
| YD Bio Ltd (YDES) | 2025-12-31 | $16.64M | n/m |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
Compare LUDG, FCHS, ADVB, BGLC side by side · Screen every company in Services-Medical Laboratories ↗